HueDx

HueDx is a biotechnology and healthcare startup founded in 2017 and headquartered in the United States. The company's slogan, "Accelerating time-to-market for Rapid, Quantitative, Assay-based (RQA) diagnostic tests," reflects its core focus. HueDx offers a Rapid, Quantitative, Assay-based (RQA) test development and launch platform, eliminating the need to develop physical devices and software for launching an RQA product. This innovation makes flagship or complimentary diagnostics accessible to a wider range of companies, including those who may not have previously considered such endeavors, as well as veterans of the process. HueDx's most recent investment was a $655.00K Seed Round investment on 30 July 2020. The details of the investors involved in this round are not presently disclosed. HueDx's strategic positioning within the biotechnology and healthcare industries, along with its innovative approach to accelerating the time-to-market for diagnostic tests, makes it a compelling venture for potential investors to consider.